• Investing Ideas
  • /
  • Global Pharmaceuticals & Biotech Dollar's Gain Retailers' Pain
335 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

BNTX

BioNTech
US$94.12-1.7%-29.4%US$22.4bUS$127.40PE7.5xE-30.5%n/a

PRTA

Prothena
US$25.09-8.9%-48.9%US$1.3bUS$65.72PS14.8xE25.9%n/a

VRNA

Verona Pharma
US$15.30-7.2%-21.9%US$1.2bUS$33.14PB5xE58.3%n/a

IMCR

Immunocore Holdings
US$61.610.6%21.2%US$3.1bUS$84.14PS12.3xE29.3%n/a

ARCT

Arcturus Therapeutics Holdings
US$33.76-12.7%119.2%US$908.7mUS$67.89PS5.4xE58.7%n/a

NGNE

Neurogene
US$45.0624.0%n/aUS$579.2mUS$49.50PB3.1xE-17.8%n/a

AVIR

Atea Pharmaceuticals
US$3.94-1.5%15.2%US$331.6mUS$4.67PB0.6xE14.0%n/a

OABI

OmniAb
US$5.27-1.7%46.8%US$612.9mUS$9.63PS9.5xE25.5%n/a

CBAY

CymaBay Therapeutics
US$32.480.1%262.5%US$3.7bUS$32.50PS120xE54.8%n/a

ANRO

Alto Neuroscience
US$14.43-0.8%n/aUS$385.4mUS$33.31PE-11.8xE-21.9%n/a

APGE

Apogee Therapeutics
US$66.22-4.5%n/aUS$3.4bUS$85.80PB8.8xE-27.0%n/a

ARDX

Ardelyx
US$8.02-4.8%93.7%US$1.9bUS$13.31PS15xE60.6%n/a

EPIX

ESSA Pharma
US$9.304.1%204.9%US$411.4mUS$20.08PB2.9xE-12.0%n/a

IONS

Ionis Pharmaceuticals
US$42.16-2.3%18.4%US$6.1bUS$56.72PS7.8xE27.9%n/a

HARP

Harpoon Therapeutics
US$23.010.2%243.4%US$492.3mUS$23.77PS13.2xE10.6%n/a

DNTH

Dianthus Therapeutics
US$26.445.1%n/aUS$775.2mUS$34.83PS218.7xE-15.6%n/a

AKRO

Akero Therapeutics
US$25.85-9.2%-30.6%US$1.8bUS$51.25PB3.3xE6.3%n/a

XNCR

Xencor
US$22.76-0.2%-20.0%US$1.4bUS$37.82PS8.3xE22.1%n/a

TYRA

Tyra Biosciences
US$16.10-14.9%0.8%US$842.7mUS$23.40PB3.8xE-1.3%n/a

FDMT

4D Molecular Therapeutics
US$32.0212.2%81.1%US$1.6bUS$50.11PS76.9xE-2.6%n/a

MGX

Metagenomi
US$11.35-0.8%n/aUS$425.9mUS$21.40PS11.2xE5.3%n/a

CRBU

Caribou Biosciences
US$5.397.4%12.1%US$486.8mUS$20.00PS14.1xE-3.1%n/a

MGTX

MeiraGTx Holdings
US$6.283.5%14.2%US$403.3mUS$21.60PS28.8xE52.8%n/a

ORTX

Orchard Therapeutics
US$16.700.9%188.9%US$380.1mUS$16.00PS17.4xE12.5%n/a
Page 2 of 14
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.